Bioactive Compounds
-
A8405 Cytarabine1 CitationSummary: cytotoxic agent, blocks DNA synthesis -
B3261 RO4987655Summary: MEK inhibitor -
B1642 WYE-125132 (WYE-132)Target: mTORSummary: ATP-competitive mTOR inhibitor, highly potent -
B2075 AmbrisentanTarget: ETA ReceptorsSummary: ETA-receptor antagonist -
B1302 AmsacrineSummary: Topoisomerase 2 inhibitor -
B1054 Resiquimod (R-848)6 CitationTarget: Toll-like receptors (TLRs)Summary: Toll-like receptor 7/8 (TLR7/8) dual agonist; for autoimmune disease models -
B1253 Tenofovir maleateSummary: Reverse transcriptase inhibitor -
B3680 GriseofulvinSummary: Microtubule associated inhibitor -
B4727 B-Raf IN 1Summary: B-Raf inhibitor -
B6586 (-)-Lobeline hydrochlorideSummary: nicotinic receptor partial agonist

